Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Clinical trial NCT03913234 · UNKNOWN

Trial details

NCT number: NCT03913234
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Postmenopausal Metastatic Breast Cancer

Start date: 2019-06-10
Primary completion: 2023-10-30
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.